The crystal structure of wild type PA endonuclease (2009/H1N1/CALIFORNIA) in complex with SJ000988569
收藏Protein Data Bank Japan2023-10-25 更新2026-03-21 收录
下载链接:
https://pdbj.org/mine/summary/7mty
下载链接
链接失效反馈官方服务:
资源简介:
The crystal structure of wild type PA endonuclease (2009/H1N1/CALIFORNIA) in complex with SJ000988569 Descriptor: 2-(2,6-difluorophenyl)-5-hydroxy-N-[2-(2-methoxypyridin-4-yl)ethyl]-6-oxo-3,6-dihydropyrimidine-4-carboxamide, Hexa Vinylpyrrolidone K15, MANGANESE (II) ION, ... Authors: Cuypers, M.G, Slavish, J.P, Rankovic, Z, White, S.W. Deposit date: 2021-05-13 Release date: 2022-05-18 Last modified: 2023-10-25 Method: X-RAY DIFFRACTION (2.38 Å) Cite: Chemical scaffold recycling: Structure-guided conversion of an HIV integrase inhibitor into a potent influenza virus RNA-dependent RNA polymerase inhibitor designed to minimize resistance potential. Eur.J.Med.Chem., 247, 2023
野生型PA核酸内切酶(2009/H1N1/加利福尼亚株)与SJ000988569形成的复合物晶体结构,SJ000988569的结构式描述为:2-(2,6-二氟苯基)-5-羟基-N-[2-(2-甲氧基吡啶-4-基)乙基]-6-氧代-3,6-二氢嘧啶-4-甲酰胺,体系包含六乙烯基吡咯烷酮K15、锰(II)离子…… 作者:Cuypers M.G.、Slavish J.P.、Rankovic Z.、White S.W.。存储日期:2021-05-13;发布日期:2022-05-18;最后修改日期:2023-10-25。实验方法:X射线衍射(分辨率2.38埃)。引用文献:《化学骨架再利用:基于结构导向策略将HIV整合酶抑制剂转化为强效流感病毒RNA依赖RNA聚合酶抑制剂,以最大限度降低耐药潜力》,《欧洲医药化学杂志》,247卷,2023年。
创建时间:
2021-05-13



